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Pseudomonas aeruginosa is a primary cause of opportunistic infections. We have sequenced and annotated the
genomes of two P. aeruginosa clinical isolates evidencing different antibiotic susceptibilities. Registered differ-
ences in the composition of their accessory genomes may provide clues on P. aeruginosa strategies to thrive in
different environments like infection loci.
Pseudomonas aeruginosa is a versatile Gram-negative bacte-
rium that is ubiquitous in a wide variety of environments,
including health care centers (5). Therefore, it is not surprising
that P. aeruginosa has emerged as a leading cause of nosoco-
mial acute infections, including pneumonia, bacteremia, uro-
sepsis, and wound infections (3, 4, 6–8). During a seasonal
epidemiological survey carried out in a collaboration with Hos-
pital de Braga, located in northern Portugal, that handles
roughly 500 P. aeruginosa isolates per year, we have selected
two clinical isolates obtained from sputum samples from two
patients with pneumonia, named 138244 and 152504, repre-
sentatives of allelic sequence types ST175 (widely disseminated
and associated with multidrug resistance) and ST560 (rare
allele), respectively, for further analysis. Besides allelic varia-
tion, we have observed that, under standardized experimental
procedures, isolate 138244 did not produce pigments and evi-
denced an antibiotic-panresistant phenotype, whereas 152504
produced a large amount of pyocyanin pigment and was sus-
ceptible to all antibiotics tested. To unveil the global genetic
variations that may justify, at least in part, the registered phe-
notypic differences, a comparative genomics strategy was set.
In this context, we have determined the full genome sequences
of the two clinical isolates using the high-throughput system
Illumina Genome Analyzer IIx. Sequencing of the susceptible
strain genome yielded 4,135,435 paired-end sequence reads,
whereas the panresistant isolate yielded 3,866,276 paired-end
sequence reads. Raw pair-ended reads were de novo assembled
using the Ray assembler (version 1.30) (2). The minimum
contig size was set to 500 nucleotides, which generated 381
contigs for isolate 138244 (N50, 32,770 bp) and 389 contigs for
isolate 152504 (N50, 32,834 bp), respectively. For both isolates,
a percent GC content of 66.2% was estimated. Based on as-
sembly data, the estimated genome sizes of isolates 138244 and
152504 are 6,357.409 bp and 6,813.259 bp, respectively, evi-
dencing an almost 0.5-Mbp difference between the two iso-
lates. Both genome drafts were annotated using the NCBI
Prokaryotic Genomes Automatic Annotation Pipeline, reveal-
ing that isolate 138244 apparently possesses 6,153 open read-
ing frames (ORFs), whereas isolate 152504 has 6,454 ORFs. A
comparative genomics analysis of the genomes of the two iso-
lates and the fully sequenced genomes of P. aeruginosa
(GenBank accession numbers NC_011770.1, NC_008463.1,
NC_009656.1, and NC_002516.2), using the RAST server (1),
provided the first clues on the accessory genomes of both
isolates. Most of the unique genes identified in each isolate are
annotated as “hypothetical proteins.” However, it was possible
to verify that for the panresistant isolate, some of the unique
genes are related to antibiotic resistance (e.g., puromycin N-
acetyltransferase-like gene), phages, and transposase elements.
In the case of the susceptible isolate, unique genes include
functions like resistance to arsenic and chromate and cell wall
biogenesis (e.g., glycosyltransferases). Further exploitation of
the genomic information of these two clinical isolates will pro-
vide valuable information regarding the importance of the
accessory genome component in the strategies used by P.
aeruginosa clinical strains to infect hospitalized patients.
Nucleotide sequence accession numbers. This genome shot-
gun project has been deposited in DDBJ/EMBL/GenBank under
accession numbers AEVV00000000 (P. aeruginosa 138244) and
AEVW00000000 (P. aeruginosa 152504). The versions described
in this paper are the first versions, DDBJ/EMBL/GenBank ac-
cession numbers AEVV01000000 and AEVW01000000.
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